Back to Journals » Research Reports in Clinical Cardiology » Volume 11

Atrioventricular Nodal Reentrant Tachycardia: Current Perspectives

Authors Matta M, Devecchi C, De Vecchi F, Rametta F

Received 3 June 2019

Accepted for publication 2 December 2019

Published 7 January 2020 Volume 2020:11 Pages 1—6


Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Editor who approved publication: Dr Richard Kones

Mario Matta, Chiara Devecchi, Federica De Vecchi, Francesco Rametta

Cardiology Division, Sant’Andrea Hospital, Vercelli, Italy

Correspondence: Mario Matta
Cardiology Division, Sant’Andrea Hospital, Corso M. Abbiate 21, Vercelli 13100, Italy
Tel +39 0161 593424

Abstract: Atrioventricular nodal reentrant tachycardia (AVNRT) is the most common, highly symptomatic paroxysmal supraventricular tachycardia. Despite pharmacological treatment and vagal maneuvers for acute termination, catheter ablation has emerged as the first line treatment for the cure of AVNRT episodes. Several studies during recent years have investigated the efficacy, safety and long-term effect of both radiofrequency ablation and cryoablation of the slow pathway for the treatment of AVNRT. Innovations such as mapping systems and dedicated catheters have contributed by extending the indication to AVNRT ablation, even in particular subset populations such as children and congenital heart disease patients. We performed this review with the aim aim of summarizing and discussing current perspectives on the treatment of AVNRT, mainly focusing on catheter ablation energy sources and long-term results.

Keywords: AVNRT, catheter ablation, radiofrequency, cryoablation

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]